Transferring Phosphorus Containing Group (e.g., Kineases, Etc.(2.7)) Patents (Class 435/194)
-
Patent number: 9315786Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.Type: GrantFiled: April 17, 2014Date of Patent: April 19, 2016Assignee: Intrexon CorporationInventors: Thomas D. Reed, Amy H. Atzel
-
Patent number: 9284603Abstract: An object of the present invention is to provide an amplification method that inhibits amplification caused by erroneous annealing of a primer. Primers X1 and X2 are used in amplification of a target sequence including a target site showing a polymorphism. The primer X1 includes a sequence A1? and a sequence E1. The sequence A1? is complementary to a partial sequence A1 in a template nucleic acid, and has, in its 3? region, a base x1? complementary to a first base x1 at the target site in a 5? region of the sequence A1. The sequence E1 is noncomplementary to a partial sequence B1 adjacent to the 3? end of the partial sequence A1 in the template nucleic acid, and is bound to the 5? end of the partial sequence A1?. The primer X2 includes a sequence A2?. The sequence A2? is complementary to a partial sequence A2 in the template nucleic acid, and has, in its 3? region, a base x2? complementary to a second base x2 at the target site in a 5? region of the partial sequence A2.Type: GrantFiled: January 21, 2011Date of Patent: March 15, 2016Assignee: ARKRAY, Inc.Inventor: Toshiya Hosomi
-
Patent number: 9260720Abstract: The invention provides genetic constructs which comprise a senescence-specific promoter operably linked to at least one coding sequence, which encodes at least one polypeptide having phosphoenolpyruvate carboxykinase (PCK) activity and/or pyruvate orthophosphate dikinase (PPDK) activity. The constructs have the ability to cause, in transgenic plants, remobilisation of nitrogen during leaf senescence, such that nitrogen can be transported from the leaves to other regions of the plants. The invention provides plant cells and plants transformed with such constructs, methods of producing transgenic plants, and methods of increasing the rate of nitrogen remobilisation and growth rate in senescent plants. The invention also provides harvested plant leaves, such as tobacco leaves, that have been transformed with the genetic constructs, and to smoking articles comprising such harvested plant leaves.Type: GrantFiled: February 25, 2010Date of Patent: February 16, 2016Assignee: BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITEDInventors: Julian Michael Hibberd, Lucy Elisabeth Taylor, Anna Elizabeth Leiss
-
Patent number: 9243272Abstract: Disclosed is a thermostable DNA polymerase preparation which can illimitably reduce the risk of false positivity in the detection of a subject microorganism utilizing a gene amplification reaction and therefore enables the selective amplification of DNA for detecting the subject microorganism even when the amount of the subject microorganism is small and therefore the amount of DNA collected therefrom is extremely small, and can be produced at a reduced cost. Also disclosed is a method for quantifying or quantifying/identifying a subject organism to be detected rapidly, conveniently and with high sensitivity using the preparation of the present invention.Type: GrantFiled: January 15, 2010Date of Patent: January 26, 2016Assignees: HOKKAIDO MITSUI CHEMICALS INC., NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMAInventors: Homare Tabata, Hiroshi Minami, Hideki Niimi, Isao Kitajima, Tomohiro Ueno, Shiroh Hayashi, Masashi Mori
-
Patent number: 9212386Abstract: Methods and devices for detecting a target enzyme include an anchored or trapped peptide complex. The peptide complex includes an anchor particle immobilized on a sample analysis device or trapped in a reaction receptacle including a filter, a peptide, with at least one enzyme cleavage site for a target enzyme, bound to the anchor particle, at least one detectable label, and at least one first tag bound to the peptide on a side of the enzyme cleavage site opposite the anchor particle. When the target enzyme is present in the sample, the enzyme cleaves the peptide at the enzyme cleavage site, permitting the cleaved peptide to reach the test zone of a sample analysis device such that the first tag binds to the immobilized second tag and a signal is detected at the test zone.Type: GrantFiled: July 19, 2012Date of Patent: December 15, 2015Assignee: Rapid Pathogen Screening, Inc.Inventors: Uma Mahesh Babu, Robert P. Sambursky, Robert W. VanDine
-
Patent number: 9212352Abstract: Polynucleotides having nucleic acid binding activity are provided. Methods of stabilizing a nucleic acid duplex are provided. Methods of promoting the annealing of complementary nucleic acid strands are provided. Methods of increasing the processivity of a DNA polymerase are provided. Methods of enhancing the activity of a nucleic acid modification enzyme are provided. Fusion proteins are provided. Methods of using fusion proteins are provided. Kits are provided.Type: GrantFiled: September 14, 2012Date of Patent: December 15, 2015Assignee: APPLIED BIOSYSTEMS, LLCInventors: Patrick K. Martin, David A. Simpson
-
Patent number: 9194006Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.Type: GrantFiled: July 6, 2012Date of Patent: November 24, 2015Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Jules Chen, Michelle M. Tabb, Michael Aye, Emberlee Eleazar
-
Patent number: 9193959Abstract: The present invention provides improved variants of T7 RNA polymerase by introducing novel mutations which lead to improved thermostability of the enzyme. According to the invention, amino acid substitutions at the positions Val426, Ser633, Val650, Thr654, Ala702, Val795, and combinations thereof are advantageous.Type: GrantFiled: March 23, 2011Date of Patent: November 24, 2015Assignee: Roche Diagnostics Operations, Inc.Inventors: Harald Sobek, Johann-Peter Thalhofer, Rainer Mueller, Manfred Schmidt, Michael Greif, Armin Ruf, Christian Rudolph
-
Patent number: 9181534Abstract: The subject invention relates to compositions comprising an enzyme mixture which comprises a first enzyme and a second enzyme, where the first enzyme comprises a DNA polymerization activity and the second enzyme comprises an 5?-3? exonuclease activity and a reduced DNA polymerization activity. The invention also relates to the above compositions in kit format and methods for high fidelity DNA synthesis using the subject compositions of the invention.Type: GrantFiled: December 21, 2001Date of Patent: November 10, 2015Assignee: Agilent Technologies Inc.Inventors: Holly Hogrefe, Michael Borns, Joseph A. Sorge
-
Patent number: 9138459Abstract: In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuron. The present invention also provides methods of screening compounds that modulate activity of an ActRII protein and/or an ActRII ligand. The compositions and methods provided herein are useful in treating diseases associated with abnormal activity of an ActRII protein and/or an ActRII ligand.Type: GrantFiled: August 17, 2012Date of Patent: September 22, 2015Assignee: Acceleron Pharma Inc.Inventors: John Knopf, Jasbir Seehra
-
Patent number: 9127319Abstract: An in vitro diagnostic method for determining invasive potential of cancer comprising measuring MLK4 gene expression in a cancer cell sample, wherein MLK4 gene overexpression is indicative of an invasive cancer, preferably a colorectal, bladder, breast, gastric, melanoma, lung, ovary or GMB cancer.Type: GrantFiled: June 15, 2010Date of Patent: September 8, 2015Inventors: Alberto Bardelli, Miriam Martini
-
Patent number: 9115391Abstract: The present invention provides a method for detecting a mutation capable of detecting a mutation with high sensitivity and high reliability in one reaction system. Using primers (Xmt) and (Xwt), a target nucleic acid sequence whose objective base to be detected is a mutant-type is amplified with amplification efficiency higher than a target nucleic acid sequence whose objective base to be detected is a normal-type. The (Xmt) is a primer that is complementary to a region including a mutant-type base in the template nucleic acid and has a base complementary to a mutant-type base at a 3? region, and the (Xwt) is a primer that is complementary to a region including a normal-type base in the template nucleic acid and has a base complementary to a normal-type base at a 3? region. It is preferable that amplification efficiency by the (Xmt) with reference to a mutant-type template nucleic acid is higher than that by the (Xwt) with reference to a normal-type template nucleic acid.Type: GrantFiled: July 2, 2009Date of Patent: August 25, 2015Assignee: ARKRAY, Inc.Inventors: Mitsuharu Hirai, Toshiya Hosomi, Aki Iguchi
-
Patent number: 9102944Abstract: Provided are methods, compositions, and kits for cloning of DNA using DNA topoisomerase. The methods comprise (I) combining into a mixture (A) a first polynucleotide comprising an origin of replication, a selectable marker, two topoisomerase recognition sequences, and two nicking agent recognition sequences, each of the topoisomerase recognition sequences being within 50 nucleotides of at least one of the nicking agent recognition sequences and each of the two nicking agent recognition sequences being nicked, with (B) a sequence-specific topoisomerase and (C) a second polynucleotide having 5? hydroxyl on each end; and (II) transforming the mixture into a host organism, thereby cloning the second polynucleotide. Formation or purification of a DNA-protein adduct prior to the addition of the second polynucleotide is not required. Also provided are vector sequences to facilitate performance of the methods and methods for modifying a vector of interest to render it useful in the disclosed methods.Type: GrantFiled: October 10, 2012Date of Patent: August 11, 2015Assignee: DNA Twopointo, Inc.Inventors: Jon E. Ness, Jeremy S. Minshull
-
Patent number: 9102924Abstract: Disclosed are mutant DNA polymerases having improved extension rates relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. The mutant polymerases overcome the inhibitory effects by an intercalating dye. Therefore, the mutant polymerases are useful in a variety of disclosed methods in combination with an intercalating dye. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.Type: GrantFiled: April 16, 2009Date of Patent: August 11, 2015Assignee: Roche Molecular Systems, Inc.Inventors: Keith A. Bauer, Ellen Fiss, David H. Gelfand, Edward S. Smith, Shawn Suko, Olga Budker, Nancy Schoenbrunner, Susanne Stoffel, Thomas Myers
-
Patent number: 9090947Abstract: A method for detecting a mutation related to the gene encoding OAS1. This and other disclosed mutations correlate with resistance of humans to viral infection including hepatitis C. Also provided is a therapeutic agent consisting of a protein or polypeptide encoded by the mutated gene, or a polynucleotide encoding the protein or polypeptide. Inhibitors of human OAS1, including antisense oligonucleotides, methods, and compositions specific for human OAS1, are also provided.Type: GrantFiled: May 28, 2013Date of Patent: July 28, 2015Assignee: Kineta Two, LLCInventors: Shawn P. Iadonato, Charles L. Magness, Gary Rosenberg, Christina A. Scherer, Thierry Guillaudeux
-
Patent number: 9045740Abstract: The invention relates to modified T7-related RNA polymerases and methods of use thereof. In some embodiments, the invention relates to modified T7-related RNA polymerases that transcribe RNA with reduced abortive cycling and increased efficiency compared with native T7-related RNA polymerases.Type: GrantFiled: February 25, 2013Date of Patent: June 2, 2015Assignee: University of MassachusettsInventors: Craig T. Martin, Luis Ramirez-Tapia
-
Publication number: 20150147780Abstract: Disclosed herein are embodiments for a novel method of producing an organic compound, including harvesting at least one organic compound from an organism or cell line genetically engineered with a gene for at least one proton-pump protein.Type: ApplicationFiled: November 24, 2014Publication date: May 28, 2015Inventors: Eugene Dinescu, Vincent Dinescu
-
Publication number: 20150147753Abstract: The present invention provides a method for producing a hyperactive MuA transposase variant comprising at least one single-amino-acid change, the method comprising the steps of modifying the nucleic acid encoding wild type MuA transposase in at least one of the positions 59, 97, 160, 179, 233, 254, 258, 302, 335, 340, 345, 374, 447, 464, 478, 482, 483, 487, 495, 507, 539, 594 or 617 so that the modified nucleic acid encodes a MuA transposase variant comprising at least one single-amino-acid change in its amino acid sequence, wherein said single-amino-acid change results in higher enzyme activity of the variant when compared to the wild type MuA transposase. The present invention also provides hyperactive MuA transposases and kits comprising the same.Type: ApplicationFiled: May 30, 2013Publication date: May 28, 2015Inventor: Harri SAVILAHTI
-
Patent number: 9040276Abstract: The invention relates to compositions and methods directed to chimeric DNA polymerases, which comprise a mutated DNA binding polypeptide domain and a mutated or wild-type DNA polymerase polypeptide domain.Type: GrantFiled: July 17, 2006Date of Patent: May 26, 2015Assignee: Agilent Technologies, Inc.Inventor: Michael Borns
-
Publication number: 20150140603Abstract: The invention relates to a method for producing a lysate used for cell-fee protein biosynthesis, comprising the following steps: a) a genomic sequence in an organism, which codes for an essential translation product that reduces the yield of cell-fee protein biosynthesis, is replaced by the foreign DNA located under a suitable regulatory element, said foreign DNA coding for the essential translation product that additionally contains a marker sequence; b) the organism cloned according to step a) is cultivated; c) the organisms from the culture obtained in step b) are lysed; and d) the essential translation product is eliminated by means of a separation process that is selective for the marker sequence.Type: ApplicationFiled: March 24, 2014Publication date: May 21, 2015Applicant: RINA-NETZWERK RNA TECHNOLOGIEN GMBHInventors: Michael Gerrits, Jan Strey, Wolfgang Stiege
-
Patent number: 9034608Abstract: The invention relates to a polypeptide having a mutation at one or more position corresponding to T219 of SEQ ID NO: 55, wherein the polypeptide has at least 50% sequence identity with SEQ ID NO: 55, and wherein the polypeptide has permease activity.Type: GrantFiled: October 11, 2011Date of Patent: May 19, 2015Assignee: DSM IP ASSETS, B.V.Inventors: Hendrik Wouter Wisselink, Antonius Jeroen Adriaan Van Maris, Jacobus Thomas Pronk, Paul Klaassen, Rene Marcel De Jong
-
Publication number: 20150133478Abstract: Nucleic acids and proteins having a mutant C-RAF sequence, and methods of identifying patients having cancer who are likely to benefit from a combination therapy and methods of treatment are provided.Type: ApplicationFiled: March 7, 2013Publication date: May 14, 2015Applicant: Dana-Farber Cancer Institute, Inc.Inventors: Caroline Emery, Rajee Antony, Levi A. Garraway
-
Patent number: 9029142Abstract: Gene encoding human glucokinase mutant is provided. The gene has the nucleotide sequence chosen from the nucleotide sequence listed as SEQ ID NO:2 and the nucleotide sequence wherein the ORF region encodes the same amino acid sequence as the one encoded by ORF region (position 487 to 1884) of SEQ ID NO:2 and the rest of the region is same as the non-ORF region of SEQ ID NO:2. Human glucokinase mutant encoded by the gene, the recombinant vectors carrying the gene, the hosts comprising the vectors, pharmaceutical compositions thereof, uses thereof, and methods for treating and preventing diseases by using the same are provided. The human glucokinase mutant encoded by the gene has higher activity than that of the wild type human glucokinase, and thus provides a new way of controlling blood glucose and/or preventing and/or treating disturbance of carbohydrate metabolism, especially preventing and treating diabetes.Type: GrantFiled: July 7, 2011Date of Patent: May 12, 2015Inventor: Haidong Huang
-
Publication number: 20150126387Abstract: A method for screening an AMPK activator, wherein inhibition of an interaction between prohibitin and AMPK is used as an index is provided. Besides, an AMPK activator comprising, as an active ingredient, a compound inhibiting an interaction between prohibitin and AMPK, and a prohibitin-AMPK complex are also provided.Type: ApplicationFiled: May 16, 2013Publication date: May 7, 2015Applicant: Kyorin Pharmaceutical Co., Ltd.Inventors: Tomohiro Ide, Naoki Kobayashi, Yunike Akasaka, Takashi Komine, Koji Murakami
-
Publication number: 20150125438Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.Type: ApplicationFiled: March 5, 2013Publication date: May 7, 2015Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Bum Joon Kim, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Hwain Jang, Jung Soon Ha
-
Patent number: 9023633Abstract: The present invention provides, among other things, chimeric DNA polymerases containing heterologous domains having sequences derived from at least two DNA polymerases that have at least one distinct functional characteristics (e.g., elongation rate, processivity, error rate or fidelity, salt tolerance or resistance) and methods of making and using the same. In some embodiments, the present invention can combine desired functional characteristics (e.g., high processivity; high elongation rate; thermostability; resistance to salt, PCR additives (e.g., PCR enhancers) and other impurities; and high fidelity) of different DNA polymerases in a chimeric polymerase.Type: GrantFiled: November 3, 2009Date of Patent: May 5, 2015Assignee: Kapa BiosystemsInventors: Bjarne Faurholm, Paul McEwan, William Bourn, Gavin Rush
-
Publication number: 20150118228Abstract: A chimeric ErbB ligand binding molecule is disclosed along with its pharmaceutically acceptable salt forms. The molecule is a protein that as part of its sequence includes the sequence of SEQ ID NOS: 1, 2, or 3. The molecule can be fused to an IgGFc and especially IgGFc containing cysteine to serine changes in the hinge region. For example, the fusion can be to IgG 1Fc DNA sequences that encode the binding molecules are also contemplated as well as vectors containing such DNA sequences and hosts that contain such vectors. Pharmaceutical compositions are contemplated that contain the binding molecule along with a pharmaceutically acceptable excipient.Type: ApplicationFiled: April 25, 2013Publication date: April 30, 2015Inventor: Jason E. Hill
-
Publication number: 20150119561Abstract: The present invention provides methods of synthesizing moenomycin analogs of Formula (I). The present invention also provides compositions comprising a compound of Formula (I) and kits for synthesizing compounds of Formula (I).Type: ApplicationFiled: April 5, 2013Publication date: April 30, 2015Inventors: Daniel Evan Kahne, Suzanne Walker Kahne, Emma Doud, Christian M. Gampe, Hirokazu Tsukamoto
-
Publication number: 20150118715Abstract: Methods, devices, and kits are provided for performing PCR in <20 seconds cycle, with improved efficiency and yield.Type: ApplicationFiled: May 23, 2013Publication date: April 30, 2015Applicant: University of Utah Research FoundationInventors: Carl T. Wittwer, Steven Jared Farrar
-
Publication number: 20150104433Abstract: The present invention relates to a method for preparing an expression vector encoding a tailored recombinase, which tailored recombinase is capable of recombining asymmetric target sequences within the long terminal repeat (LTR) of proviral DNA of a plurality of retrovirus strains inserted into the genome of a host cell, as well as to the obtained expression vector, cells transfected with this, expressed recombinase and pharmaceutical compositions comprising the expression vector, cells and/or recombinase. Pharmaceutical compositions are useful, e.g., in treatment and/or prevention of retrovirus infection. In particular, asymmetric target sequences present in a plurality of HIV strains are disclosed, as well as tailored recombinases capable of combining these sequences (Tre 3.0 and 4.0) and expression vectors encoding them.Type: ApplicationFiled: December 4, 2014Publication date: April 16, 2015Inventors: Joachim Hauber, Jan Chemnitz, Frank Buchholz, Janet Chusainow
-
Publication number: 20150104790Abstract: Compositions and methods are provided for improved reverse transcriptases and their uses in reverse transcription where the improvement may include increased temperature, increased salt, increased activity and/or increased dUTP tolerance.Type: ApplicationFiled: October 16, 2014Publication date: April 16, 2015Applicant: NEW ENGLAND BIOLABS, INC.Inventors: Yinhua Zhang, Thomas C. Evans, JR.
-
Publication number: 20150104848Abstract: The present invention provides thermostable enzymes, such as DNA polymerases and restriction endonucleases, that are substantially free from contamination with nucleic acids. The invention also provides methods for the production of these enzymes, and kits comprising these enzymes which may be used in amplifying or sequencing nucleic acid molecules, including through use of the polymerase chain reaction (PCR).Type: ApplicationFiled: October 23, 2014Publication date: April 16, 2015Inventors: Adam Goldstein, A. John Hughes
-
Patent number: 9005945Abstract: A polynucleotide comprising a nucleotide sequence encoding a thymidine kinase wherein at least one of the nucleotides corresponding to the splice donor site nucleotides is replaced by another nucleotide and wherein the nucleotides of the splice acceptor sites are not altered.Type: GrantFiled: December 10, 2013Date of Patent: April 14, 2015Assignee: MolMed SpAInventors: Francesca Salvatori, Stefania Massa, Marina Radrizzani, Salvatore Toma
-
Patent number: 9005935Abstract: The present invention provides new compositions for transposase-mediated fragmenting and tagging DNA targets. The invention relates to the surprising discovery that use of manganese ions (Mn2+) in transposase reactions improves the transposase reaction. It also relates to the surprising discovery that Mg2+ ions can be used in a transposase reaction with wild-type and/or engineered transposases at levels much higher than previously thought. The invention provides for the use of naturally-occurring transposases in in vitro reactions, as well as improved schemes for cleaving, tagging, and amplifying target DNA.Type: GrantFiled: May 11, 2012Date of Patent: April 14, 2015Assignee: Agilent Technologies, Inc.Inventor: Alexander S. Belyaev
-
Patent number: 8999676Abstract: Provided are compositions comprising recombinant DNA polymerases that include amino acid substitutions, insertions, deletions, and/or exogenous features that confer modified properties upon the polymerase for enhanced single molecule sequencing. Such properties can include enhanced metal ion coordination, reduced exonuclease activity, reduced reaction rates at one or more steps of the polymerase kinetic cycle, decreased branching fraction, altered cofactor selectivity, increased yield, increased thermostability, increased accuracy, increased speed, increased readlength, and the like. Also provided are nucleic acids which encode the polymerases with the aforementioned phenotypes, as well as methods of using such polymerases to make a DNA or to sequence a DNA template.Type: GrantFiled: July 5, 2011Date of Patent: April 7, 2015Assignee: Pacific Biosciences of California, Inc.Inventors: Robin Emig, Lei Jia, Satwik Kamtekar, Erik Miller, Colleen Cutcliffe, Walter Lee
-
Patent number: 8999674Abstract: Provided herein are systems and methods for nucleotide incorporation reactions. The systems comprise polymerases having altered nucleotide incorporation kinetics and are linked to an energy transfer donor moiety, and nucleotide molecules linked with at least one energy transfer acceptor moiety. The donor and acceptor moieties undergo energy transfer when the polymerase and nucleotide are proximal to each other during nucleotide binding and/or nucleotide incorporation. As the donor and acceptor moieties undergo energy transfer, they generate an energy transfer signal which can be associated with nucleotide binding or incorporation. Detecting a time sequence of the generated signals, or the change in the signals, can be used to determine the order of the incorporated nucleotides, and can therefore be used to deduce the sequence of the target molecule.Type: GrantFiled: July 30, 2012Date of Patent: April 7, 2015Assignee: Life Technologies CorporationInventors: Joseph Beechem, Theo Nikiforov, Vi-En Choong, Xinzhan Peng, Guobin Luo, Cheng-Yao Chen, Michael Previte
-
Patent number: 8999679Abstract: The present invention provides a method for the assembly of a polynucleic acid sequence from a plurality of nucleic acid sequences in which the polynucleic acid sequence is of a formula Nn+1, in which N represents a nucleic acid sequence and where n is 1 or greater than 1 and each N may be the same or a different nucleic acid sequence, in which the method comprises: (i) providing a first nucleic acid sequence N1 which has an oligonucleotide linker sequence L13 at the 3?-end of the nucleic acid sequence; (ii) providing a second nucleic acid sequence N2 which optionally has an oligonucleotide linker sequence L23? at the 3?-end of the nucleic acid sequence and which has an oligonucleotide linker sequence L25? at the 5?-end of the nucleic acid sequence, wherein the 5?-end linker sequence L25? of nucleic acid sequence N2 is complementary to the 3?-end linker sequence L13? of nucleic acid sequence N1; (iii) optionally providing one or more additional nucleic acid sequences N, wherein nucleic acid sequence N2 has anType: GrantFiled: December 18, 2009Date of Patent: April 7, 2015Assignee: Iti Scotland LimitedInventors: Austin Che, Tom Knight, Barry Canton, Jason Kelly, Reshma Shetty
-
Publication number: 20150094209Abstract: The present invention provides autonomous replication sequences (ARSs) isolated from Nannochloropsis that support the replication of episomal DNA molecules (EDMs) in eukaryotic cells. The ARSs and EDMs provided herein can be used for expressing genes in organisms including algae and heterokonts.Type: ApplicationFiled: December 6, 2013Publication date: April 2, 2015Applicant: Synthetic Genomics, Inc.Inventors: Peter DeHoff, Leah Soriaga, Srividya Akella
-
Publication number: 20150094211Abstract: The present disclosure provides compositions, methods, kits, systems and apparatus that are useful for nucleic acid polymerization. In particular, modified polymerases and biologically active fragments thereof are provided that allow for nucleic acid amplification. In some aspects, the disclosure provides modified polymerases having lower systematic error as compared to a reference polymerase. In one aspect, the disclosure relates to modified polymerases useful for nucleic acid sequencing, genotyping, copy number variation analysis, paired-end sequencing and other forms of genetic analysis. In some aspects, the disclosure relates to modified polymerases useful for the generation of nucleic acid libraries or nucleic acid templates. In some aspects, the disclosure relates to the identification of homologous amino acid mutations that can be transferred across classes or families of polymerases to provide novel polymerases with altered properties.Type: ApplicationFiled: September 30, 2014Publication date: April 2, 2015Inventors: Peter VANDER HORN, Daniel MAZUR, Theo NIKIFOROV, Mindy LANDES, Eileen TOZER
-
Publication number: 20150093403Abstract: The invention is directed to a isolated a canine circoviruses associated with canine respiratory and gastrointestinal disease, and isolated nucleic acids sequences and polypeptides thereof. The invention also relates to antibodies against antigens from canine circoviruses. The invention also relates to iRNAs which target nucleic acid sequences of the canine circovirus. The invention is related to methods for detecting the presence or absence of canine circoviruses in an animal. The invention is also related to immunogenic compositions for inducing an immune response against canine circoviruses in an animal.Type: ApplicationFiled: April 3, 2013Publication date: April 2, 2015Inventors: W. Ian Lipkin, Amit Kapoor, Edward J. Dubovi
-
Patent number: 8993298Abstract: Novel proteins having DNA polymerase are described which have utility in amplification reactions and have improved properties over Bst polymerase such as for example enhanced reverse transcriptase activity.Type: GrantFiled: August 31, 2012Date of Patent: March 31, 2015Assignee: New England Biolabs, Inc.Inventors: Jennifer Ong, Thomas C. Evans, Jr., Nathan Tanner
-
Publication number: 20150087557Abstract: Enzyme compositions and their method of use that provide ready-to-use master mixtures. The compositions comprise a modified thermophilic DNA polymerase lacking 5?-3? and 3?-5? exonuclease activity premixed with T4 DNA polymerase, Klenow fragment and T4 polynucleotide kinase and all other necessary components, including reaction buffer and nucleoside triphosphates, required to perform DNA blunting, phosphorylation, and single nucleotide extension reactions in one tube and in two steps. Among other benefits, the mixture of different enzymes, buffers and nucleoside triphosphates is stable during prolonged storage.Type: ApplicationFiled: September 24, 2014Publication date: March 26, 2015Inventors: Judita LUBIENE, Arturas Berezniakovas, Arvydas Lubys
-
Publication number: 20150087045Abstract: The present disclosure includes a crystalline form and a crystal structure of HCV RNA polymerase and HCV RNA polymerase in a complex with an RNA template primer molecule. In other aspects, the disclosure provides methods of using the crystal structures and structural coordinates to identify homologous proteins and to design or identify agents that can modulate the function of the HCV RNA polymerase and HCV RNA polymerase in a complex with an RNA template primer molecule.Type: ApplicationFiled: January 11, 2013Publication date: March 26, 2015Inventors: Thomas E. Edwards, Angela Man Iu Lam, Ralph T. Mosley, Eisuke Murakami
-
Publication number: 20150087027Abstract: The present invention is directed to methods and compositions for adding tails of specific lengths to a substrate polynucleotide. The invention also contemplates methods and compositions for immobilization of tailed substrates to a solid support. The disclosure contemplates that the attenuator molecule is any biomolecule that associates with a tail sequence added to a substrate polynucleotide and controls the addition of a tail sequence to the 3? end of the substrate polynucleotide. The sequence that is added to the substrate polynucleotide is referred to herein as a tail sequence, or simply a tail, and the process of adding a nucleotide to a substrate polynucleotide is referred to herein as tailing.Type: ApplicationFiled: March 13, 2013Publication date: March 26, 2015Inventors: Vladimir Makarov, Laurie Kurihara
-
Patent number: 8986968Abstract: There is provided a polypeptide having thermostable DNA polymerase activity and comprising or consisting of an amino acid sequence with at least 55% identity to Thermodesulfatator indicus DNA polymerase I Large fragment shown in SEQ ID NO: 1 or in SEQ ID NO:32.Type: GrantFiled: February 13, 2009Date of Patent: March 24, 2015Assignee: Genesys Biotech Ltd.Inventors: Duncan Clark, Nicholas Morant
-
Publication number: 20150079602Abstract: The present invention refers to methods for selectively recognizing a base pair in a DNA sequence by a polypeptide, to modified polypeptides which specifically recognize one or more base pairs in a DNA sequence and, to DNA which is modified so that it can be specifically recognized by a polypeptide and to uses of the polypeptide and DNA in specific DNA targeting as well as to methods of modulating expression of target genes in a cell.Type: ApplicationFiled: January 13, 2014Publication date: March 19, 2015Inventors: Ulla Bonas, Jens Boch, Sebastian Schornack, Thomas Lahaye
-
Publication number: 20150079635Abstract: Provided herein are methods and kits for isothermal nucleic acid amplifications that use an oligocation-oligonucleotide conjugate primer for amplifying a target nucleic acid to generate amplicons. Isothermal DNA amplification methods that employ a strand displacing DNA polymerase and polyamine-oligonucleotide conjugate primer are also provided.Type: ApplicationFiled: September 16, 2013Publication date: March 19, 2015Applicant: General Electric CompanyInventors: Ryan Charles Heller, John Richard Nelson
-
Publication number: 20150072380Abstract: The present invention relates to the identification of novel nucleic acid sequences, designated herein as 7p, 8k, 7E, 9G, 8Q and 203, in a host cell which effect protein production. The present invention also provides host cells having a mutation or deletion of part or all of the gene encoding 7p, 8k, 7E, 9G, 8Q and 203, which are presented in FIG. 1, and are SEQ ID NOS.: 1-6, respectively. The present invention also provides host cells further comprising a nucleic acid encoding a desired heterologous protein such as an enzyme.Type: ApplicationFiled: September 23, 2014Publication date: March 12, 2015Applicant: DANISCO US INC.Inventors: Elizabeth A. Bodie, Steve Kim
-
Publication number: 20150064747Abstract: Modified Epstein Barr Virus DNA polymerase for use in nucleic acid amplification, including isothermal nucleic acid amplification, in vitro are provided. Methods using and kits comprising Epstein Barr Virus DNA polymerase and its variants of this invention for nucleic acid amplification in vitro, including isothermal DNA amplification, are also provided.Type: ApplicationFiled: August 22, 2014Publication date: March 5, 2015Inventor: David Isaac Dorsky
-
Publication number: 20150064716Abstract: The present invention provides native Goodpasture antigen binding protein isoforms, monoclonal antibodies directed against such proteins, and methods for their use.Type: ApplicationFiled: November 17, 2014Publication date: March 5, 2015Inventors: Juan Saus, Fernando Revert